Journal
TRENDS IN MOLECULAR MEDICINE
Volume 25, Issue 7, Pages 640-655Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2019.03.006
Keywords
-
Funding
- Canadian Institutes of Health Research
- Heart and Stroke Foundation
- Canadian Institutes of Health Research (MOP) [378189]
Ask authors/readers for more resources
Ischemic cardiovascular complications remain a major cause of mortality in people with type 2 diabetes (T2D). Individuals with T2D may have a reduced ability to revascularize ischemic, tissues due to abnormal production of circulating provascular progenitor cells. This 'regenerative cell exhaustion' process is intensified by increasing oxidative stress and inflammation and during T2D progression. Chronic exhaustion may be mediated by changes in the bone marrow microenvironment that dysregulate the wingless related integration site network, a central pathway maintaining the progenitor cell pool. Restoration of vascular regenerative cell production by reducing glucotoxicity with contemporary antihyperglycemic agents, by reducing systemic inflammation postbariatric surgery, or by modulating progenitor cell provascular functions using exosomal manipulation, may provide unique approaches for mitigating ischemic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available